| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |